DNA methylation and expression status of glutamate receptor genes in patients with oral squamous cell carcinoma

Rigi-Ladiz, Mohammad Ayoub; Baranzehi, Tayebeh; Hassanpour, Behnaz; Ashraf, Mohammad Javad; Kordi-Tamandani, Dor Mohammad

doi:10.1016/j.mgene.2019.100555

Cited by 1 publication

(1 citation statement)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Using an mGluR5 agonist, DHPG, and an mGluR5 antagonist, MPEP, Choi and colleagues showed that mGluR5 signaling enhances metastasis, invasion, and adhesion in vitro, supporting its role as an oncogene ( Table 1 ) [ 98 ]. The epigenetic regulation of GRM5 may also be involved in OSCC [ 130 ].…”

Section: The Role Of Metabotropic Glutamate Receptors In Various Cancersmentioning

confidence: 99%

Implications of a Neuronal Receptor Family, Metabotropic Glutamate Receptors, in Cancer Development and Progression

Eddy

Eddin

Fateeva

et al. 2022

Cells

View full text Add to dashboard Cite

Cancer is the second leading cause of death, and incidences are increasing globally. Simply defined, cancer is the uncontrolled proliferation of a cell, and depending on the tissue of origin, the cancer etiology, biology, progression, prognosis, and treatment will differ. Carcinogenesis and its progression are associated with genetic factors that can either be inherited and/or acquired and are classified as an oncogene or tumor suppressor. Many of these genetic factors converge on common signaling pathway(s), such as the MAPK and PI3K/AKT pathways. In this review, we will focus on the metabotropic glutamate receptor (mGluR) family, an upstream protein that transmits extracellular signals into the cell and has been shown to regulate many aspects of tumor development and progression. We explore the involvement of members of this receptor family in various cancers that include breast cancer, colorectal cancer, glioma, kidney cancer, melanoma, oral cancer, osteosarcoma, pancreatic cancer, prostate cancer, and T-cell cancers. Intriguingly, depending on the member, mGluRs can either be classified as oncogenes or tumor suppressors, although in general most act as an oncogene. The extensive work done to elucidate the role of mGluRs in various cancers suggests that it might be a viable strategy to therapeutically target glutamatergic signaling.

show abstract

Section: The Role Of Metabotropic Glutamate Receptors In Various Cancersmentioning

confidence: 99%

Implications of a Neuronal Receptor Family, Metabotropic Glutamate Receptors, in Cancer Development and Progression

Eddy

Eddin

Fateeva

et al. 2022

Cells

View full text Add to dashboard Cite

show abstract

DNA methylation and expression status of glutamate receptor genes in patients with oral squamous cell carcinoma

Cited by 1 publication

References 22 publications

Implications of a Neuronal Receptor Family, Metabotropic Glutamate Receptors, in Cancer Development and Progression

Implications of a Neuronal Receptor Family, Metabotropic Glutamate Receptors, in Cancer Development and Progression

Contact Info

Product

Resources

About